145 related articles for article (PubMed ID: 37958891)
1. The Biological Assessment of Shikonin and β,β-dimethylacrylshikonin Using a Cellular Myxofibrosarcoma Tumor Heterogeneity Model.
Lohberger B; Kaltenegger H; Eck N; Glänzer D; Leithner A; Kretschmer N
Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958891
[TBL] [Abstract][Full Text] [Related]
2. Shikonin derivatives cause apoptosis and cell cycle arrest in human chondrosarcoma cells via death receptors and MAPK regulation.
Lohberger B; Glänzer D; Kaltenegger H; Eck N; Leithner A; Bauer R; Kretschmer N; Steinecker-Frohnwieser B
BMC Cancer; 2022 Jul; 22(1):758. PubMed ID: 35820864
[TBL] [Abstract][Full Text] [Related]
3. Establishment of a novel cellular model for myxofibrosarcoma heterogeneity.
Lohberger B; Stuendl N; Leithner A; Rinner B; Sauer S; Kashofer K; Liegl-Atzwanger B
Sci Rep; 2017 Mar; 7():44700. PubMed ID: 28304377
[TBL] [Abstract][Full Text] [Related]
4. Influence of silibinin and β-β-dimethylacrylshikonin on chordoma cells.
Jahanafrooz Z; Stallinger A; Anders I; Kleinegger F; Lohberger B; Durchschein C; Bauer R; Deutsch A; Rinner B; Kretschmer N
Phytomedicine; 2018 Oct; 49():32-40. PubMed ID: 30217260
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of c-MYC with involvement of ERK/JNK/MAPK and AKT pathways as a novel mechanism for shikonin and its derivatives in killing leukemia cells.
Zhao Q; Assimopoulou AN; Klauck SM; Damianakos H; Chinou I; Kretschmer N; Rios JL; Papageorgiou VP; Bauer R; Efferth T
Oncotarget; 2015 Nov; 6(36):38934-51. PubMed ID: 26472107
[TBL] [Abstract][Full Text] [Related]
6. β,β-Dimethylacrylshikonin Induces Apoptosis in Melanoma Cell Lines by NOXA Upregulation.
Stallinger A; Kretschmer N; Kleinegger F; Brvar L; Liegl-Atzwanger B; Prokesch A; Durchschein C; Bauer R; Deutsch A; Rinner B
J Nat Prod; 2020 Feb; 83(2):305-315. PubMed ID: 31961147
[TBL] [Abstract][Full Text] [Related]
7. Comparative Gene Expression Analysis in WM164 Melanoma Cells Revealed That
Kretschmer N; Deutsch A; Durchschein C; Rinner B; Stallinger A; Higareda-Almaraz JC; Scheideler M; Lohberger B; Bauer R
Molecules; 2018 Oct; 23(11):. PubMed ID: 30380804
[TBL] [Abstract][Full Text] [Related]
8. Shikonin and its derivatives inhibit the epidermal growth factor receptor signaling and synergistically kill glioblastoma cells in combination with erlotinib.
Zhao Q; Kretschmer N; Bauer R; Efferth T
Int J Cancer; 2015 Sep; 137(6):1446-56. PubMed ID: 25688715
[TBL] [Abstract][Full Text] [Related]
9. Reactive oxygen species-mediated activation of the Akt/ASK1/p38 signaling cascade and p21(Cip1) downregulation are required for shikonin-induced apoptosis.
Ahn J; Won M; Choi JH; Kim YS; Jung CR; Im DS; Kyun ML; Lee K; Song KB; Chung KS
Apoptosis; 2013 Jul; 18(7):870-81. PubMed ID: 23546866
[TBL] [Abstract][Full Text] [Related]
10. Shikonin inhibits triple-negative breast cancer-cell metastasis by reversing the epithelial-to-mesenchymal transition via glycogen synthase kinase 3β-regulated suppression of β-catenin signaling.
Chen Y; Chen ZY; Chen L; Zhang JY; Fu LY; Tao L; Zhang Y; Hu XX; Shen XC
Biochem Pharmacol; 2019 Aug; 166():33-45. PubMed ID: 31071331
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of Novel Shikonin Derivatives and Pharmacological Effects of Cyclopropylacetylshikonin on Melanoma Cells.
Durchschein C; Hufner A; Rinner B; Stallinger A; Deutsch A; Lohberger B; Bauer R; Kretschmer N
Molecules; 2018 Oct; 23(11):. PubMed ID: 30380765
[TBL] [Abstract][Full Text] [Related]
12. Endoplasmic reticulum stress-mediated autophagy protects against β,β-dimethylacrylshikonin-induced apoptosis in lung adenocarcinoma cells.
Wang H; Zhang G
Cancer Sci; 2018 Jun; 109(6):1889-1901. PubMed ID: 29676829
[TBL] [Abstract][Full Text] [Related]
13. The inhibitory effects of shikonin and β,β-dimethylacrylshikonin on tramadol metabolism in vitro and in vivo.
Jin M; Shi D; Jin H; Zhou Z; Wang C
J Pharm Pharmacol; 2020 Sep; 72(9):1232-1238. PubMed ID: 32424860
[TBL] [Abstract][Full Text] [Related]
14. Chemical screen identifies shikonin as a broad DNA damage response inhibitor that enhances chemotherapy through inhibiting ATM and ATR.
Wang F; Jin S; Mayca Pozo F; Tian D; Tang X; Dai Y; Yao X; Tang J; Zhang Y
Acta Pharm Sin B; 2022 Mar; 12(3):1339-1350. PubMed ID: 35530159
[TBL] [Abstract][Full Text] [Related]
15. β, β-Dimethylacrylshikonin induces mitochondria-dependent apoptosis of human lung adenocarcinoma cells in vitro via p38 pathway activation.
Wang HB; Ma XQ
Acta Pharmacol Sin; 2015 Jan; 36(1):131-8. PubMed ID: 25434989
[TBL] [Abstract][Full Text] [Related]
16. Shikonin Derivatives Inhibit Inflammation Processes and Modulate MAPK Signaling in Human Healthy and Osteoarthritis Chondrocytes.
Lohberger B; Kaltenegger H; Eck N; Glänzer D; Sadoghi P; Leithner A; Bauer R; Kretschmer N; Steinecker-Frohnwieser B
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328817
[TBL] [Abstract][Full Text] [Related]
17. Shikonin inhibits the proliferation and induces the apoptosis of human HepG2 cells.
Yingkun N; Lvsong Z; Huimin Y
Can J Physiol Pharmacol; 2010 Dec; 88(12):1138-46. PubMed ID: 21164560
[TBL] [Abstract][Full Text] [Related]
18. Shikonin induces apoptosis of lung cancer cells via activation of FOXO3a/EGR1/SIRT1 signaling antagonized by p300.
Jeung YJ; Kim HG; Ahn J; Lee HJ; Lee SB; Won M; Jung CR; Im JY; Kim BK; Park SK; Son MJ; Chung KS
Biochim Biophys Acta; 2016 Nov; 1863(11):2584-2593. PubMed ID: 27452907
[TBL] [Abstract][Full Text] [Related]
19. Shikonin inhibits proliferation of melanoma cells by MAPK pathway-mediated induction of apoptosis.
Lee JH; Han SH; Kim YM; Kim SH; Yoo ES; Woo JS; Jung GH; Jung SH; Kim BS; Jung JY
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33403388
[TBL] [Abstract][Full Text] [Related]
20. Shikonin suppresses proliferation and induces apoptosis in human leukemia NB4 cells through modulation of MAPKs and c‑Myc.
Shan ZL; Zhong L; Xiao CL; Gan LG; Xu T; Song H; Yang R; Li L; Liu BZ
Mol Med Rep; 2017 Sep; 16(3):3055-3060. PubMed ID: 28713949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
